Navigation Links
Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients

over the course of two years. Baranzini et al. measured the expression level of 70 genes—including a number involved in interferon interactions and immune regulation—at each time point.

The authors used statistical analyses to search for gene expression profiles that were associated with patients' therapeutic outcomes. They looked for patterns in analyses of single genes, gene pairs, and gene triplets, and found their model's predictive accuracy increased with gene number. They also looked for genes that showed different expression patterns over the two years based on patient response, time passed, and patient response over time. These analyses identified genes that increased activity independently of clinical response (interferon can activate genes that have no effect on disease), as well as genes that were associated with a good or poor response. Some of these genes were also the best predictors of patient response before therapy was started.

This approach can predict the probability of a good or poor clinical response with up to 86% accuracy. Baranzini et al. offer hypotheses to explain how the observed gene activity might produce the differential responses to therapy—for example, a poor response may stem from downstream signaling events rather than from problems with drug metabolism. But the authors caution that the mechanisms connecting these genetic signatures to specific outcomes—and the mechanisms that produce a positive interferon response—have yet to be established. For now, these patterns should be thought of as markers. Still, these results suggest that doctors could one day tailor MS patients' treatments to their molecular profile, and perhaps take some of the uncertainty out of this capricious disease.


'"/>

Source:Public Library of Science


Page: 1 2

Related biology news :

1. Circles Of DNA Might Help Predict Success Of Stem Cell Transplantation
2. Chromosome Deletion Predicts Aggressive Neuroblastoma
3. Measuring Enzymes At End Of Cancer Pathway Predicts Outcome Of Tarceva, Taxol
4. Analysis Of Human Genome To Predict The Development Of Illnesses
5. Computational Tool Predicts How Drugs Work In Cells, Advancing Efforts To Design Better Medicines
6. Predicting success
7. Predicting chemotherapy outcome
8. Predicting successful outcomes in living-donor liver transplants
9. Genes In The Interferon System Important In Systemic Lupus Erythematosus
10. New Vaccine To Be Used For First Time In Polio Outbreak Response
11. Newly Discovered Role for Heart Response Enzyme May Yield Better Heart Failure Therapy
Post Your Comments:
(Date:5/22/2013)... insects and wild plants have slowed in recent years, ... the University of Leeds and the Naturalis Biodiversity Centre ... in the diversity of species in Britain, Belgium and ... the picture brightened markedly after 1990, with a slowdown ... and wild plants. , Professor Bill Kunin, ...
(Date:5/21/2013)... concept of "place" is increasingly being considered in ... have a new resource that can help them ... with the places in their lives. , ... new book co-edited by the Pacific Northwest Research ... human-centered approach to conservation. The book is published ...
(Date:5/21/2013)... a new method for delivering molecules into single, ... surface. The technique could find applications in drug ... Bulk electroporation a technique used to deliver ... cell membrane that are caused by exposing them ... method of cell transfection. (Cell transfection is the ...
Breaking Biology News(10 mins):Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3Single-cell transfection tool enables added control for biological studies 2
... Few specimens inspire greater thrills among fossil collectors than ... lobsters, spiders and insects went extinct more than ... beautifully preserved condition. In rare instances, an entire population ... finds evidence for ancient environment and behavior in these ...
... it,s difficult to observe behavior in fossil specimens that are ... to find a modern, living, species that has some similarities ... David L. Meyer, University of Cincinnati professor of geology and ... as brachiopods. Although they resemble clams or other shelled mollusks, ...
... Hopkins scientists report that they have refined a means of ... to exact locations at precise times. This new ... manipulating single molecules, allowing them to see how molecules in ... whether cells will grow, die, move or divide. A report ...
Cached Biology News:Fossils record ancient migrations and trilobite orgies 2Paleontologists audition modern examples of ancient behavior 2Hopkins researchers use light to move molecules 2
(Date:5/21/2013)... Norristown, PA (PRWEB) May 21, 2013 ... company, today announced that Dr. Charles Signorino, the Company’s ... on April 1, 2013 after 32 years of service. ... Adolfo Gomez, Emerson’s current President, has been named as ... recognized luminary in the pharmaceutical industry, having made a ...
(Date:5/21/2013)... Md. , May 21, 2013  Synthetic Biologics, Inc. ... prevention and treatment of serious infectious diseases, announced today that ... the 2 nd Annual Marcum LLP MicroCap Conference on ... at the Grand Hyatt Hotel. Mr. Riley is ... A live webcast of Synthetic Biologics, presentation can be accessed ...
(Date:5/21/2013)... Bed bugs have become so widespread in the past ... to chemical-based pesticides for help to completely get rid of ... solutions present, the company advised the public to kill ... According to My Cleaning Products, chemical-based pesticides are not as ... shared that the pests have already developed immunity to the ...
(Date:5/21/2013)... 21, 2013 NANONEX CORPORATION, a ... , today announced the successful delivery and installation ... the NX-M200B, to a major Japanese manufacturing company. ... fully-automated, production-ready, advanced nanoimprint lithography tool that has ... and substrate sizes and types. Based on Nanonex ...
Breaking Biology Technology:Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2
... to $11.6 million ... Net Income increased 118.8% to $2.5 million, ... (OTC Bulletin Board: CHME) ("China Medicine" or "the ... over-the-counter,pharmaceuticals, traditional Chinese medicines ("TCM"), nutritional and,dietary-supplements, medical ...
... MOUNTAIN VIEW, California, August 13 BN,ImmunoTherapeutics, ... with the,National Cancer Institute (NCI) in the ... Agreement (CRADA) the NCI and BN,ImmunoTherapeutics will ... prostate cancer. Under the CRADA, BN ImmunoTherapeutics ...
... Aug. 13 Anthera Pharmaceuticals,Inc., a privately ... the completion of a $19 Million,equity financing. ... (New,York, NY) and HBM BioCapital (Cayman Islands) ... Director of Caxton Advantage Venture Partners (the,General ...
Cached Biology Technology:China Medicine Announces Strong Second Quarter 2008 Results 2China Medicine Announces Strong Second Quarter 2008 Results 3China Medicine Announces Strong Second Quarter 2008 Results 4China Medicine Announces Strong Second Quarter 2008 Results 5China Medicine Announces Strong Second Quarter 2008 Results 6China Medicine Announces Strong Second Quarter 2008 Results 7China Medicine Announces Strong Second Quarter 2008 Results 8China Medicine Announces Strong Second Quarter 2008 Results 9China Medicine Announces Strong Second Quarter 2008 Results 10China Medicine Announces Strong Second Quarter 2008 Results 11BN ImmunoTherapeutics Announces Partnership With National Cancer Institute 2BN ImmunoTherapeutics Announces Partnership With National Cancer Institute 3Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman 2Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman 3
... OPTIMA is a fully automated microplate ... science labs in academia and industry. ... principles: Fluorescence Intensity including ... Fluorescence including DELFIATM High-Performance ...
... The kit measures mitochondria intactness ... mitochondrial membrane potential. Features and Benefits: ... method for staining isolated mitochondria and ... Contains all the reagents required for ...
... Identical to the DH-2000, but comes with ... switch up to 5 Hz) The ... the continuous spectrum of deuterium and tungsten halogen ... combined-spectrum light source produces a powerful, stable output ...
... an enhanced ChemStation for the ... 2000 and Windows XP operating ... all new 7500 ICP-MS instruments ... new ChemStation using Microsofts Windows ...
Biology Products: